Currently out of the existing stock ratings of Mohit Bansal, 153 are a BUY (62.7%), 87 are a HOLD (35.66%), 4 are a SELL (1.64%).

Mohit Bansal

Work Performance Price Targets & Ratings Chart

Analyst Mohit Bansal, currently employed at WELLS FARGO, carries an average stock price target met ratio of 67.02% that have a potential upside of 27.49% achieved within 217 days.

Mohit Bansal’s has documented 487 price targets and ratings displayed on 37 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on IRWD, Ironwood Pharmaceuticals at 05-Jan-2026.

Wall Street Analyst Mohit Bansal

Analyst best performing recommendations are on KRTX (KARUNA THERAPEUTICS).
The best stock recommendation documented was for KRTX (KARUNA THERAPEUTICS) at 11/18/2019. The price target of $115 was fulfilled within 1 day with a profit of $19 (19.79%) receiving and performance score of 197.92.

Average potential price target upside

of $99.35 (16.94%) on REGN (REGENERON PHARMACEUTICALS).
of $90.61 (15.08%) on LLY (ELI LILLY AND COMPANY).
of $52.45 (20.13%) on VRTX (VERTEX PHARMACEUTICALS).

AGIO Agios Pharm ALXN Alexion Pharmaceuticals AMGN Amgen BIIB Biogen BMRN Biomarin Pharmaceutical CALA Calithera Biosciences CHRS Coherus BioSciences CTMX CytomX Therapeutics EPZM Epizyme FOLD Amicus Therapeutics GILD Gilead Sciences LLY Eli Lilly and Company MYOK MyoKardia MYOV Myovant Sciences Ltd PFE Pfizer RDUS Schnitzer Steel Industries REGN Regeneron Pharmaceuticals VRTX Vertex Pharmaceuticals ABBV AbbVie BMY Bristol-Myers Squibb Company KRTX Karuna Therapeutics MRK Merck mpany SNSE Sensei Biotherapeutics STTK Shattuck Labs NBIX Neurocrine Biosciences BOLD Audentes Therapeutics CERE Cerevel Therapeutics Holdings HALO Halozyme Therapeutics ONCE Spark Therapeutics KDNY Chinook Therapeutics IRWD Ironwood Pharmaceuticals TVTX Travere Therapeutics JAZZ Jazz Pharmaceuticals PLC XENE Xenon Pharmaceuticals BNTX BioNTech SE FBRX Forte Biosciences IDYA Ideaya Biosciences

Show more stocks

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score